A scientist leading the development of Oxford University’s coronavirus vaccine says the just-started phase 2/3 trial only has a 50:50 chance of success, because the virus is di
AstraZeneca has joined with Oxford University to develop and distribute the institution’s potential coronavirus vaccine, ahead of an early trial readout as soon as June or July.
GSK looks like it is starting to show the benefit of a revamp of its business under chief executive Emma Walmsley, with recent product launches driving a 10% rise in sales
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.